H-0447-2025 Class III Terminated

Recalled by GMP Laboratories Of America Inc — Anaheim, CA

FDA food recall H-0447-2025 was initiated by GMP Laboratories Of America Inc on Jun 24, 2025 and is designated Class III. Reason for recall: Downstream recall of a dietary supplement ingredient that was manufactured out of specifications. The recall status is terminated (terminated Feb 24, 2026). Affected quantity: ~185,482 capsules.

Recall details

Product Type
Food
Report Date
Aug 20, 2025
Initiation Date
Jun 24, 2025
Termination Date
Feb 24, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
~185,482 capsules

Product description

Lithium Orotate 2.5; 60 vegetarian capsules, Dietary Supplement; Distributed by Mecene LLC. 447 Sutter St., Suite 405, San Fransisco, CA 94108 2.5 mg UPC#: X002T4OPLL 10 mg UPC#: X0031AXVE9

Reason for recall

Downstream recall of a dietary supplement ingredient that was manufactured out of specifications.

Distribution pattern

Distribution was to a single customer who received product in California and Oklahoma.

Code information

2.5mg Lot #: 21822 Expire date: 09/2026 10mg Lot#: 21108; 22649 Expire date: 10/2025; 01/2028

Source

Dataset
openFDA food recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for H-0447-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 15, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for H-0447-2025. Report a data issue: hello@regdatalab.com.